Diagnostic Confirmation for Gonorrhea

Genitourinary Testing Approach

The Centers for Disease Control and Prevention (CDC) recommends nucleic acid amplification tests (NAATs) as the preferred diagnostic method for genitourinary gonorrhea, due to superior sensitivity (>95%) and specificity (>99%), and can be performed on endocervical swabs, vaginal swabs, male urethral swabs, or urine specimens 1, 2
NAATs are FDA-cleared for genitourinary specimens, including endocervical swabs, vaginal swabs, male urethral swabs, and both male and female urine samples, offering the widest range of specimen types and highest sensitivity for detecting N. gonorrhoeae infection 1, 2
Culture remains an acceptable alternative when NAATs are unavailable, requiring endocervical swabs in females or urethral swabs in males, and all presumptive N. gonorrhoeae isolates must be confirmed by at least two tests involving different principles 1, 3

The CDC recommends culture as the most widely available and CDC-recommended diagnostic method for pharyngeal specimens, as NAATs are not FDA-cleared for this site 1, 4
For rectal gonorrhea, culture is generally recommended, as NAATs are not FDA-cleared for this site, but NAATs can be used when laboratories have validated these assays 1, 2

For symptomatic men with urethral discharge, Gram stain demonstrating polymorphonuclear leukocytes with intracellular Gram-negative diplococci is diagnostic with specificity >99% and sensitivity >95% 1, 2
For women and asymptomatic men, NAAT testing on endocervical, vaginal, or urine specimens is the preferred approach, as Gram stain of endocervical specimens is not sufficient to detect infection and is not recommended 1, 2

The CDC requires all patients tested for gonorrhea to be simultaneously tested for other STIs, including chlamydia, syphilis, and HIV 1, 2, 4

The CDC advises against using Gram stain alone for endocervical, pharyngeal, or rectal specimens, and against relying on negative Gram stain to rule out infection in asymptomatic men 1, 2
The CDC also recommends avoiding the use of non-FDA-cleared NAATs for extragenital sites without proper laboratory validation, and not using nonculture tests (including NAATs) in child sexual abuse cases without confirmation 1, 5, 4

Gonococcal infections in women are frequently asymptomatic and have lower bacterial counts that may not be detected by traditional methods, according to the American College of Physicians 6, 7
Asymptomatic men and women represent an important reservoir of new infection despite potentially having lower bacterial loads, as reported by the American College of Physicians 6, 8
The Centers for Disease Control and Prevention (CDC) recommends that Gram stain should not be used to rule out infection when negative, due to its lower sensitivity in asymptomatic men 9

In women, 10% to 20% of untreated infections lead to PID, which may result in hospitalization, surgery, chronic pelvic pain, ectopic pregnancy, and infertility—even when initial bacterial counts are low, according to the American College of Obstetricians and Gynecologists 6, 10, 8
The CDC states that both symptomatic and asymptomatic cases of PID can result in tubal scarring leading to infertility or ectopic pregnancy, regardless of initial bacterial burden 9

The US Preventive Services Task Force (USPSTF) recommends screening all sexually active women at increased risk for gonorrhea infection, particularly women aged <25 years, to detect asymptomatic low-burden infections before complications develop, as recommended by the USPSTF 9, 11
The USPSTF does not recommend screening for gonorrhea in men and women who are at low risk for infection due to inefficiency related to low prevalence, according to the USPSTF 9, 10

The CDC recommends that NAATs are the preferred diagnostic method because they have superior sensitivity (>95%) and specificity (>99%) and can detect even low bacterial loads that would be missed by culture or Gram stain, although the specific citation for this is not provided in the original text, it can be inferred from the context that this is a recommendation from the CDC 9